Updates from The Motley Fool

Latest updates on Anthera Pharmaceuticals, Inc. from Fool.com.


Stock Performance

ANTH vs. S&P 500 | 2 Year Performance
ANTH 1-Day Stock Chart
ANTH 5-Day Stock Chart
ANTH 1-Month Stock Chart
ANTH 3-Month Stock Chart
ANTH 6-Month Stock Chart
ANTH 1-Year Stock Chart
ANTH 2-Year Stock Chart
ANTH 5-Year Stock Chart
View Interactive ANTH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Anthera Pharmaceuticals, Inc..
Current Price: $3.57
Prev Close: $3.70
Open: $3.70
Bid: $3.10
Ask: $4.50
Day's Range: $3.45 - $3.70
52wk Range: $2.28 - $11.65
Volume: 433,135
Avg Vol 549,103
Market Cap: $142.36M
P/E (ttm): -3.74
EPS (ttm): -$0.99
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Anthera Pharmaceuticals, Inc..
CAPS Rating 3 out of 5
 
84 Outperform
5 Underperform
CAPS All Stars
 
13 Outperform
2 Underperform

How do you think Anthera Pharmaceuticals, Inc. will perform against the market?



You pick for Anthera Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Anthera Pharmaceuticals, Inc..

Anthera Pharmaceuticals Inc. is a Biopharmaceutical Company focusing on developing and commercializing products to treat serious diseases associated with inflammation including cardiovascular and autoimmune diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers